| Primary |
| Breast Cancer |
75.0% |
| Product Used For Unknown Indication |
25.0% |
|
| Skin Exfoliation |
50.0% |
| Tachycardia |
50.0% |
|
| Secondary |
| Breast Cancer |
37.6% |
| Breast Cancer Metastatic |
30.7% |
| Non-small Cell Lung Cancer |
6.4% |
| Prostate Cancer |
4.0% |
| Oesophageal Carcinoma |
3.7% |
| Squamous Cell Carcinoma |
2.5% |
| Ovarian Cancer |
2.2% |
| Chemotherapy |
1.8% |
| Gastric Cancer |
1.6% |
| Small Cell Lung Cancer Limited Stage |
1.6% |
| Prostate Cancer Metastatic |
1.2% |
| Lung Neoplasm Malignant |
1.1% |
| Product Used For Unknown Indication |
1.1% |
| Gastrooesophageal Cancer |
0.8% |
| Ill-defined Disorder |
0.8% |
| Premedication |
0.7% |
| Drug Use For Unknown Indication |
0.5% |
| Non-small Cell Lung Cancer Metastatic |
0.5% |
| Squamous Cell Carcinoma Of The Oral Cavity |
0.5% |
| Neoplasm |
0.4% |
|
| Neutropenia |
54.4% |
| White Blood Cell Count Decreased |
7.7% |
| Febrile Neutropenia |
5.3% |
| Vomiting |
5.3% |
| Neutropenic Infection |
4.1% |
| Sudden Death |
3.6% |
| Staphylococcal Infection |
2.4% |
| Neutropenic Sepsis |
1.8% |
| Tachycardia |
1.8% |
| Visual Acuity Reduced |
1.8% |
| Anal Fissure |
1.2% |
| Emotional Distress |
1.2% |
| Intestinal Perforation |
1.2% |
| Metastases To Liver |
1.2% |
| Pain |
1.2% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
1.2% |
| Pericarditis |
1.2% |
| Platelet Count Decreased |
1.2% |
| Post Procedural Complication |
1.2% |
| Pulmonary Hypertension |
1.2% |
|
| Concomitant |
| Breast Cancer |
18.2% |
| Product Used For Unknown Indication |
14.5% |
| Breast Cancer Metastatic |
9.1% |
| Metastatic Neoplasm |
7.3% |
| Non-small Cell Lung Cancer |
7.3% |
| Septic Shock |
7.3% |
| Lip And/or Oral Cavity Cancer |
5.5% |
| Lung Neoplasm Malignant |
5.5% |
| Gastric Cancer |
3.6% |
| Ill-defined Disorder |
3.6% |
| Non-small Cell Lung Cancer Metastatic |
3.6% |
| Ovarian Cancer |
3.6% |
| Chemotherapy |
1.8% |
| Drug Use For Unknown Indication |
1.8% |
| Prophylaxis Of Nausea And Vomiting |
1.8% |
| Prostate Cancer |
1.8% |
| Prostatic Specific Antigen Increased |
1.8% |
| Squamous Cell Carcinoma Of The Tongue |
1.8% |
|
| Myocardial Infarction |
9.7% |
| Visual Acuity Reduced |
9.7% |
| Inappropriate Antidiuretic Hormone Secretion |
6.5% |
| Pneumonia |
6.5% |
| Sepsis |
6.5% |
| Splenomegaly |
6.5% |
| Vomiting |
6.5% |
| White Blood Cell Count Decreased |
6.5% |
| White Blood Cell Count Increased |
6.5% |
| Drug Ineffective |
3.2% |
| Haemoptysis |
3.2% |
| Hepatic Enzyme Increased |
3.2% |
| Hyponatraemia |
3.2% |
| Loss Of Consciousness |
3.2% |
| Malignant Neoplasm Progression |
3.2% |
| Mucosal Inflammation |
3.2% |
| Musculoskeletal Pain |
3.2% |
| Neuropathy Peripheral |
3.2% |
| No Therapeutic Response |
3.2% |
| Off Label Use |
3.2% |
|
